Cargando…

The Effects of Different Invitation Schemes on the Use of Fecal Occult Blood Tests for Colorectal Cancer Screening: Systematic Review of Randomized Controlled Trials

SIMPLE SUMMARY: There is large heterogeneity in invitation schemes and participation rates in colorectal cancer screening programs offering fecal occult blood tests (nowadays mostly fecal immunochemical tests). It is unclear what the most effective invitation strategies are for fecal occult blood te...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gruner, Laura F., Amitay, Efrat L., Heisser, Thomas, Guo, Feng, Niedermaier, Tobias, Gies, Anton, Hoffmeister, Michael, Brenner, Hermann
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Systematic Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8037417/ https://www.ncbi.nlm.nih.gov/pubmed/33806234 http://dx.doi.org/10.3390/cancers13071520

Ejemplares similares

Fecal Immunochemical Tests Detect Screening Participants with Multiple Advanced Adenomas Better than T1 Colorectal Cancers
por: Gies, Anton, et al.
Publicado: (2021)

Risk Factors of Inadequate Bowel Preparation for Screening Colonoscopy
por: Amitay, Efrat L., et al.
Publicado: (2021)

Fecal Immunochemical Tests for Colorectal Cancer Screening: Is Fecal Sampling from Multiple Sites Necessary?
por: Amitay, Efrat L., et al.
Publicado: (2019)

Impact of Inadequate Bowel Cleansing on Colonoscopic Findings in Routine Screening Practice
por: Niedermaier, Tobias, et al.
Publicado: (2020)

Effect of Various Invitation Schemes on the Use of Fecal Immunochemical Tests for Colorectal Cancer Screening: Protocol for a Randomized Controlled Trial
por: Gruner, Laura Fiona, et al.
Publicado: (2020)

A single measurement of fecal hemoglobin concentration outperforms polygenic risk score in colorectal cancer risk assessment
por: Niedermaier, Tobias, et al.
Publicado: (2023)

Fecal Immunochemical Tests Combined With Other Stool Tests for Colorectal Cancer and Advanced Adenoma Detection: A Systematic Review
por: Niedermaier, Tobias, et al.
Publicado: (2016)

Consistent Major Differences in Sex- and Age-Specific Diagnostic Performance among Nine Faecal Immunochemical Tests Used for Colorectal Cancer Screening
por: Gies, Anton, et al.
Publicado: (2021)

Accuracy of a fecal immunochemical test according to outside temperature and travel time
por: Niedermaier, Tobias, et al.
Publicado: (2018)

Prevalence of Colorectal Neoplasia 10 or More Years After a Negative Screening Colonoscopy in 120 000 Repeated Screening Colonoscopies
por: Heisser, Thomas, et al.
Publicado: (2023)

Variation of Positive Predictive Values of Fecal Immunochemical Tests by Polygenic Risk Score in a Large Screening Cohort
por: Niedermaier, Tobias, et al.
Publicado: (2022)

Reproductive Factors and Colorectal Cancer Risk: A Population-Based Case-Control Study
por: Amitay, Efrat L, et al.
Publicado: (2022)

Flexible sigmoidoscopy in colorectal cancer screening: implications of different colonoscopy referral strategies
por: Niedermaier, Tobias, et al.
Publicado: (2018)

Age-specific sequence of colorectal cancer screening options in Germany: A model-based critical evaluation
por: Heisser, Thomas, et al.
Publicado: (2020)

When gold standards are not so golden: prevalence bias in randomized trials on endoscopic colorectal cancer screening
por: Brenner, Hermann, et al.
Publicado: (2023)

Probiotic/Synbiotic Treatment and Postoperative Complications in Colorectal Cancer Patients: Systematic Review and Meta-analysis of Randomized Controlled Trials
por: Amitay, Efrat L., et al.
Publicado: (2020)

Fecal occult blood versus DNA testing: indirect comparison in a colorectal cancer screening population
por: Brenner, Hermann, et al.
Publicado: (2017)

Personalized Initial Screening Age for Colorectal Cancer in Individuals at Average Risk
por: Chen, Xuechen, et al.
Publicado: (2023)

Strongly Divergent Impact of Adherence Patterns on Efficacy of Colorectal Cancer Screening: The Need to Refine Adherence Statistics
por: Heisser, Thomas, et al.
Publicado: (2021)

Impact of demographic changes and screening colonoscopy on long-term projection of incident colorectal cancer cases in Germany: A modelling study
por: Heisser, Thomas, et al.
Publicado: (2022)

Utilisation of Colorectal Cancer Screening Tests in European Countries by Type of Screening Offer: Results from the European Health Interview Survey
por: Cardoso, Rafael, et al.
Publicado: (2020)

Direct comparison of ten quantitative fecal immunochemical tests for hemoglobin stability in colorectal cancer screening
por: Gies, Anton, et al.
Publicado: (2018)

Combination of Different Fecal Immunochemical Tests in Colorectal Cancer Screening: Any Gain in Diagnostic Performance?
por: Gies, Anton, et al.
Publicado: (2019)

Stage-Specific Sensitivity of Fecal Immunochemical Tests for Detecting Colorectal Cancer: Systematic Review and Meta-Analysis
por: Niedermaier, Tobias, et al.
Publicado: (2020)

Blood-Based Protein Signatures for Early Detection of Colorectal Cancer: A Systematic Review
por: Bhardwaj, Megha, et al.
Publicado: (2017)

Screening for Colorectal Cancer by Immunochemical Fecal Occult Blood Testing
por: Saito, Hiroshi
Publicado: (1996)

Beyond familial risk: deriving risk‐adapted starting ages of screening among people with a family history of colorectal cancer
por: Chen, Xuechen, et al.
Publicado: (2023)

Fecal microRNAs, Fecal microRNA Panels, or Combinations of Fecal microRNAs with Fecal Hemoglobin for Early Detection of Colorectal Cancer and Its Precursors: A Systematic Review
por: Zhao, Zitong, et al.
Publicado: (2021)

Association of Overweight, Obesity, and Recent Weight Loss With Colorectal Cancer Risk
por: Mandic, Marko, et al.
Publicado: (2023)

Indications of substantial delay of colorectal cancer diagnoses due to COVID-19 in Germany
por: Brenner, Hermann, et al.
Publicado: (2022)

Impact of Reducing Intake of Red and Processed Meat on Colorectal Cancer Incidence in Germany 2020 to 2050—A Simulation Study
por: Niedermaier, Tobias, et al.
Publicado: (2023)

Treatment Costs of Colorectal Cancer by Sex and Age: Population-Based Study on Health Insurance Data from Germany
por: Heisser, Thomas, et al.
Publicado: (2022)

Is the association of overweight and obesity with colorectal cancer underestimated? An umbrella review of systematic reviews and meta-analyses
por: Mandic, Marko, et al.
Publicado: (2023)

The underestimated impact of excess body weight on colorectal cancer risk: Evidence from the UK Biobank cohort
por: Safizadeh, Fatemeh, et al.
Publicado: (2023)

Effect of repeated invitations on uptake of colorectal cancer screening using faecal occult blood testing: analysis of prevalence and incidence screening
por: Steele, R J C, et al.
Publicado: (2010)

Implementation of population screening for colorectal cancer by repeated fecal occult blood test in the Netherlands
por: Denters, Maaike J, et al.
Publicado: (2009)

Population-based colorectal cancer screening: comparison of two fecal occult blood test
por: Zubero, Miren B., et al.
Publicado: (2014)

Is It Necessary to Repeat Fecal Occult Blood Tests with Borderline Results for Colorectal Cancer Screening?
por: Lee, Eunyoung, et al.
Publicado: (2018)

Clinical impact of the immunochemical fecal occult blood test for colorectal cancer screening in Brazil
por: Teixeira, Cláudio R., et al.
Publicado: (2017)

Biology and Clinical Implications of Fecal Occult Blood Test Screen-Detected Colorectal Cancer
por: Mendis, Shehara, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_9v9870knfeiom4emfohndegs7h